NFAT-Specific Inhibition by dNP2-VIVIT Ameliorates Autoimmune Encephalomyelitis by Regulation of Th1 and Th17
Tài liệu tham khảo
Shaw, 1988, Identification of a putative regulator of early T cell activation genes, Science, 241, 202, 10.1126/science.3260404
Chen, 1999, Signal integration by transcription-factor assemblies: interactions of NF-AT1 and AP-1 on the IL-2 promoter, Cold Spring Harb. Symp. Quant. Biol., 64, 527, 10.1101/sqb.1999.64.527
Macian, 2005, NFAT proteins: key regulators of T-cell development and function, Nat. Rev. Immunol., 5, 472, 10.1038/nri1632
Hogan, 2010, Molecular basis of calcium signaling in lymphocytes: STIM and ORAI, Annu. Rev. Immunol., 28, 491, 10.1146/annurev.immunol.021908.132550
Feske, 2007, Calcium signalling in lymphocyte activation and disease, Nat. Rev. Immunol., 7, 690, 10.1038/nri2152
Trama, 2000, The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner, J. Immunol., 165, 4884, 10.4049/jimmunol.165.9.4884
Hogan, 2003, Transcriptional regulation by calcium, calcineurin, and NFAT, Genes Dev., 17, 2205, 10.1101/gad.1102703
Kiani, 1997, Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1, Immunity, 7, 849, 10.1016/S1074-7613(00)80403-3
Rengarajan, 2002, NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naïve T(H)cells, Nat. Immunol., 3, 48, 10.1038/ni744
Lee, 2004, A distal enhancer in the interferon-gamma (IFN-gamma) locus revealed by genome sequence comparison, J. Biol. Chem., 279, 4802, 10.1074/jbc.M307904200
Lee, 2018, Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases, Front. Immunol., 9, 2747, 10.3389/fimmu.2018.02747
Erb, 2003, Mice deficient in nuclear factor of activated T-cell transcription factor c2 mount increased Th2 responses after infection with Nippostrongylus brasiliensis and decreased Th1 responses after mycobacterial infection, Infect. Immun., 71, 6641, 10.1128/IAI.71.11.6641-6647.2003
Fonseca, 2009, NFAT1 transcription factor regulates pulmonary allergic inflammation and airway responsiveness, Am. J. Respir. Cell Mol. Biol., 40, 66, 10.1165/rcmb.2007-0102OC
Kiani, 2001, Regulation of interferon-gamma gene expression by nuclear factor of activated T cells, Blood, 98, 1480, 10.1182/blood.V98.5.1480
Agarwal, 2000, Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo, Immunity, 12, 643, 10.1016/S1074-7613(00)80215-0
Dietz, 2015, NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms, Eur. J. Immunol., 45, 1377, 10.1002/eji.201444638
Gomez-Rodriguez, 2009, Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase, Immunity, 31, 587, 10.1016/j.immuni.2009.07.009
Hermann-Kleiter, 2012, Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORγt binding to the Il17a promoter, J. Autoimmun., 39, 428, 10.1016/j.jaut.2012.07.007
Weigmann, 2008, The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis, J. Exp. Med., 205, 2099, 10.1084/jem.20072484
Mok, 2017, Calcineurin inhibitors in systemic lupus erythematosus, Best Pract. Res. Clin. Rheumatol., 31, 429, 10.1016/j.berh.2017.09.010
Azzi, 2013, Calcineurin inhibitors: 40 years later, can’t live without …, J. Immunol., 191, 5785, 10.4049/jimmunol.1390055
Fischer, 1989, Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins, Nature, 337, 476, 10.1038/337476a0
Takahashi, 1989, Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin, Nature, 337, 473, 10.1038/337473a0
Harding, 1989, A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase, Nature, 341, 758, 10.1038/341758a0
Bram, 1993, Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location, Mol. Cell. Biol., 13, 4760, 10.1128/MCB.13.8.4760
Bechstein, 2000, Neurotoxicity of calcineurin inhibitors: impact and clinical management, Transpl. Int., 13, 313, 10.1111/j.1432-2277.2000.tb01004.x
Abramowicz, 2000, Nephrotoxicity of calcineurin inhibitors: new therapeutic approaches, Transplant. Proc., 32, 3S, 10.1016/S0041-1345(00)00807-1
Miroux, 2012, In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function, Transplantation, 94, 123, 10.1097/TP.0b013e3182590d8f
Miroux, 2009, Inhibitory effects of cyclosporine on human regulatory T cells in vitro, Transplant. Proc., 41, 3371, 10.1016/j.transproceed.2009.08.043
Aramburu, 1999, Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A, Science, 285, 2129, 10.1126/science.285.5436.2129
Aramburu, 1998, Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT, Mol. Cell, 1, 627, 10.1016/S1097-2765(00)80063-5
Lim, 2016, Cell Type Preference of a Novel Human Derived Cell-Permeable Peptide dNP2 and TAT in Murine Splenic Immune Cells, PLoS ONE, 11, e0155689, 10.1371/journal.pone.0155689
Lim, 2015, dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis, Nat. Commun., 6, 8244, 10.1038/ncomms9244
Noguchi, 2004, A new cell-permeable peptide allows successful allogeneic islet transplantation in mice, Nat. Med., 10, 305, 10.1038/nm994
Yamaguchi, 2014, Patient age and the prognosis of idiopathic membranous nephropathy, PLoS ONE, 9, e110376, 10.1371/journal.pone.0110376
Alfaadhel, 2015, Management of Membranous Nephropathy in Western Countries, Kidney Dis. (Basel), 1, 126, 10.1159/000437287
Zhang, 2008, Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis, Cytokine, 42, 345, 10.1016/j.cyto.2008.03.006
Wang, 2015, Cyclosporine A Suppresses the Activation of the Th17 Cells in Patients with Primary Sjögren’s Syndrome, Iran. J. Allergy Asthma Immunol., 14, 198
Chen, 2014, Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords, J. Physiol., 592, 215, 10.1113/jphysiol.2013.263814
Khanna, 1999, Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine, Transplantation, 67, 882, 10.1097/00007890-199903270-00016
Khanna, 1999, Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells, Transplantation, 67, 614, 10.1097/00007890-199902270-00021
Kakita, 2001, Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes, Circ. Res., 88, 1239, 10.1161/hh1201.091794
Slowinski, 2002, Interaction of the endothelin system and calcineurin inhibitors after kidney transplantation, Clin. Sci. (Lond.), 103, 396S, 10.1042/CS103S396S
Choi, 2012, Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness, Immunol. Lett., 143, 170, 10.1016/j.imlet.2012.01.016
Trapp, 1999, Axonal pathology in multiple sclerosis: relationship to neurologic disability, Curr. Opin. Neurol., 12, 295, 10.1097/00019052-199906000-00008
Goverman, 2009, Autoimmune T cell responses in the central nervous system, Nat. Rev. Immunol., 9, 393, 10.1038/nri2550
Lee, 2019, Pathogenic function of bystander-activated memory-like CD4+ T cells in autoimmune encephalomyelitis, Nat. Commun., 10, 709, 10.1038/s41467-019-08482-w